Page last updated: 2024-10-23

bisbenzimidazole and Diffuse Mixed Small and Large Cell Lymphoma

bisbenzimidazole has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 1 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Research Excerpts

ExcerptRelevanceReference
"In these cells and in chronic lymphocytic leukemia cells obtained from patients, there was considerable intercell heterogeneity in apparent adduct levels."1.29Detection and quantification of melphalan-DNA adducts at the single cell level in hematopoietic tumor cells. ( Frank, AJ; Proctor, SJ; Tilby, MJ, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frank, AJ1
Proctor, SJ1
Tilby, MJ1

Other Studies

1 other study available for bisbenzimidazole and Diffuse Mixed Small and Large Cell Lymphoma

ArticleYear
Detection and quantification of melphalan-DNA adducts at the single cell level in hematopoietic tumor cells.
    Blood, 1996, Aug-01, Volume: 88, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Bisbenzimidazole; DNA Adducts; DNA, Neoplasm; Feasibility Studies

1996